Celosia Therapeutics CEO and Director of Commercialisation at Macquarie University, Dr Kathryn Sunn sit down for an interview post the company’s landmark Series A funding… Read More »Video – Interview with Celosia Therapeutics CEO Dr Kathryn Sunn
Sydney, Australia, 28 November 2024 – Celosia Therapeutics, an Australian biotech company developing advanced gene therapies for neurodegenerative diseases, has completed one of the largest… Read More »Celosia Secures Landmark $16.75M Funding for Breakthrough ALS Gene Therapy
Published online (16th Feb 2024) in the prestigious journal Neuron is the outcome of over 15 years of study by researchers at Macquarie University’s Dementia… Read More »New Research Publication
Macquarie University announces the launch of a new company, Celosia Therapeutics, dedicated to delivering gene therapies for devastating neurodegenerative conditions. The Lighthouse